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A comprehensive theory has been presented elsewhere (Anal. Chem. 53: 877-884, 1981) for the various contributions to assay imprecision in procedures that are based on sample extraction followed by "high-performance" liquid chromatography. Experimental data (1800 assays, 8400 results) for the Technicon FAST-LC system are used with this theory in an effort to understand and control the precision of clinical-laboratory procedures, both automated and manual. This study provides specific conclusions and recommendations on matters such as: standardization procedures and protocols, physical properties required in internal standards, the relative importance of different sources of imprecision and means for improving precision, the relative importance of temperature control in pretreatment and liquid-chromatographic analysis, and the precision obtainable with small sample volumes or with samples containing very low concentrations of analyte (e.g., in assays for free drugs). Automation evidently can lead to twofold greater assay precision, other factors being equal, for liquid-chromatographic procedures that include sample pretreatment. Similarly, internal standardization, properly applied, can decrease assay imprecision by twofold. (HPLC) is widely used in determining various drugs, hormones, and metabolites in body fluids (e.g., 1-3). In such clinical assays the sample must be pretreated before HPLC (e.g., 4). Many workers report day-to-day precision (CV) of 5 to 10% in the HPLC analysis of serum components, which is generally adequate.
However, increased precision may be required in pharmacokinetic studies, and precision and other performance features of an analytical determination are related; e.g., volume of sample required, sample throughput or analysis rate, construction (and cost) of the analytical system, and convethence and reliability of standardization protocols.
Therefore, there is general interest in the sources of imprecision and in means for improving precision.
For HPLC determinations involving pretreatment of the sample, we have reported (5) a general theoretical scheme that relates assay imprecision to operating conditions. Here, we apply this theory to our (4,6) precision data for the determination of various drugs in serum, illustrating how an evaluation of precision can be combined with the identification and reduction of error sources, with the aim of optimizing the overall assay. We also examine (a) the general value of internal 
Materials and Methods
These were described for the assays of theophylline (4), various anticonvulsants (4), and tricyclic antidepressants (6) with the FAST-LC system (Technicon). Our emphasis in this paper will be on the FAST-LC system configuration used in the assay of theophylline and anticonvulsants (4), which is outlined in Figure 1 . The system provides for serum pickup at the differential pumping, and the EDM module is replaced by back-extraction followed by phase separation in a debubbler before injection onto the HPLC column.
Theory
For additional details on the present approach, see ref.
5. The glossary at the end of this paper gives a full definition of each of the symbols used in the following discussion.
The corrected absorbance (A) or peak height of an HPLC analyte band (photometric detection) is the result of measurements of baseline and peak absorbance, as in Figure 2 . It is assumed in the following that A is linearly related to concentration over the range of concentrations measured. The coefficient of variation of a single absorbance measurement (4) For drift that varies linearly with time,
where S' is the fractional change in assay sensitivity (S) that occurs during the time of a single assay (assuming assays are run serially), and n' is the number of assays performed before recalibration.
A calibration cycle can be defined as that period of time 
with each drug determined at five different concentrations covering a 20-fold range in values. These data comprise three CV a (external calibr'n) (%) different assay procedures, 1800 individual assays, and 8400 CV a (Internal calibr'n) (%) experimental results (drug-concentration values). We will use these data to validate the theory (5) and to illustrate its practical application.
cv, (calibrator) (%) cv, (sample) (%)
Assay CV values (averages) for the 14 analytes at each of five concentrations are plotted in Figure 3 6, a double extraction and internal standardization are used.
Thus, these data are plotted separately in Figure 3b . during which an initial calibrator is run, followed by the analysis of some number of samples. For example, a calibration cycle for the FAST-LC system consists of calibrator plus up to 13 samples, run in serial fashion. During such a calibration cycle, the value of cud for the calibrator will be zero, 
The variances cv2 (drift-free) and cud2 (drift-related) can be further subdivided into contributions which are correctable (c) or uncorrectable (u) by internal standardization (IS):
Note 5 . For example, the parameter i might be the temperature of the system during extraction, y might refer to the variation in extraction temperature expressed as a standard deviation (e.g., ±0.5 #{176}C), and F(A:i) is the percentage change in A as a result of a unit change (1 #{176}C) in extraction temperature (i.e., F(A:i) is the value of (cv,), for y = 1). Values of cv, and o for each plot can be derived from the fitting equations of Figure 3 , as summarized in Table 2 . The agreement of experimental data in Figure 3 with equations 3c and 3d is seen to be acceptable, which confirms the applicability of equation 1 in such assay procedures.
Within and above the therapeutic range for the various drugs of Figure 3 , cv is very nearly equal to cv,. Therefore, cv, is of primary interest, and we have analyzed this term further via equation 6 . Because values for cv, are constant for different drugs and (or) concentrations in Figure 3a , we can use phenobarbital at 70 mg/L as an example. The average value of the CV for this sample and analyte was 4.1%; in comparison, the average CV for all drugs was 5.0% ( shows larger CV values (e.g., 2.1% for n' = 48) for values of n' greater than 13.
These differences in the behavior of the internal standards of Table 3 can be related to their chromatographic retention as compared with that of the analyte (phenobarbital).
Thus, primidone has a capacity factor value (k') of 1.5, which is close to that of phenobarbital In similar fashion we can analyze the data of ref. These data allow us to calculate the variance parameters shown in Table   2 for the procedure of reference 6. Note that Figure 3 and Table 2 compare two different assay procedures. For each of these procedures, internal standardization yields a twofold reduction in assay CV relative to the use of external standardization. However, the procedure for the tricyclic antidepressants (Figure 3b ) with internal standardization yields CV values of about the same magnitude as the procedure for the anticonvulsants (Figure 3a) without internal standardization.
Precision as Determined by Different Operating Parameters

Imprecision at low values of A. It is sometimes assumed
that the precision of HPLC assays at low concentrations of the analyte will be determined by the high-frequency noise in the baseline; i.e., the width of the baseline, x, in Figure 2b . In our procedures (4, 6) the absorbance difference x under assay conditions was 0.0002 A (peak-to-peak) over the range 0.1-1.0 A; i.e., detector noise did not contribute to cv,, but does contribute to o.
Assuming correction of baseline drift in the measurement of band absorbance as in Figure 2a , and a uniform distribution of data points across the 0.0002 A noise band, the precision of a single measurement of A will be given (7) Table 2 shows that this is the case, because o for the procedure of (6) (backextraction)
is only 0.0001, as compared with the sevenfold greater value (0.0007) for the procedure of (4) (single-extraction). where the variance associated with an individual step or module could be isolated and determined directly. A detailed account of this study would be tedious and largely specific to a particular commercial system (FAST-LC).
Imprecision at high values of
Therefore, we will briefly summarize our findings ( Table 4 ) (anyone wishing a more detailed account should correspond with us). Table 4 shows individual values of (cu,),2 for each step in the assay (4) for phenobarbital. Each value of (cu,),2 is further broken down into the various terms of equation 6. We note first that the contributions from steps 1-13 sum to give approximately the values found for the whole system: cu,2, 8.8 (sum) vs 8.4 (actual); cu,,2 6.5 vs 6.1; cu,,2, 1.3 vs 1.3; and cud,,2, 1.1 vs 1.1. That is, we have accounted for all error contributions in Table 4 , and equation 7 has been validated.
The error source from step 2 of Table 4 is the evaporation of sample from cups on the sampler-tray during the procedure of (4). The time required to complete the assay of a 40-cup sample tray of anticonvulsants is 5 h, and during this time there will be significant evaporation of water from later samples (8) 
A publishedstudy (8) We believe the discrepancy is due to the differential pumping scheme used for the phase separator (III of Figure 1 ) and its susceptibility to hydraulic upsets such as surging. This flow variability contributes to variance in steps 3 and 5 of Table  4 . Variation in the distribution constant K with temperature contributes negligibly to cv,, because the fraction of analyte extracted into the organic phase is near unity (see discussion of 5).
The error contribution of the evaporation-to-dryness steps (steps 7-9) was determined directly, as a combined value (Table 4) . Because the loss of these relatively nonvolatile drugs during evaporation is small, the variability of analyte loss should contribute negligibly to imprecision (5) . The major contribution to cv (steps 7-9) for the FAST-LC system appears to be that the analyte redissolves erratically into the aqueous solvent used for this purpose. About half of the total analyte entering the EDM module can be analytically accounted for in the redissolution solvent leaving the pickup fitting (V of Figure 1 ), and we believe that remaining analyte is left on the Teflon matrix of the EDM. The precision of sample injection for the FAST-LC system (4) is determined by the ability to capture a precise fraction (about 80%) of the analyte within the loop of the sample valve.
A value for (cv,), from step 11 was determined directly to be 0.04%; i.e., it is a negligible source of imprecision.
The imprecision of HPLC analysis (steps 12, 13 of Table   4 ) can be divided into detector imprecision and variation in the volume occupied by the analyte band as it leaves the column. We determined that the FAST-LC detector
contributes negligibly to imprecision. Table 5 summarizes values of (cv,) for step 13 as determined directly from the procedure of (4). Also shown in Table 5 are values of cv, after Table 5 .
Discussion
Standardization Protocols and Assay Precision
The assay protocol, including standardization, can affect assay precision. We have examined two approaches here: (a) variation in the number of samples per calibration cycle (n') and (b) the use of internal standardization. These examples illustrate the value of theory (5) for improving FAST-LC or related assays, when either precision or assay convenience are overriding considerations. Here we have assumed phenobarbital to be the analyte, with a large value of A so that HPLC assays for drugs in serum often involve internal standardization.
Because two peak measurements are required for each sample, internal standardization for the procedure (4) should yield a value of CV = cvi,., (since cud,, = 0), assuming that any error in adding internal standard to the sample is negligible. From Table 2 , this yields a within-calibration CV of 1.6%. Long-term and inter-laboratory precision will be poorer, because of imprecision in the value of S (calibration factor) assumed. However, the precision of S can be increased by replicate determination with averaging. Thus, for mk measurements of the calibrator in each calibration cycle, equation 2 gives the long-term assay CV as (1.62 + l.62/mk)"2; for m, equal to 1, 2, or 4, CV is then 2.3%, 2.0%, or 1.8%. Thus with appropriate internal standardization and adequately frequent recalibration, the FAST-LC procedure of ref. 4 can yielda long-term precision of about 2% CV. This might prove useful in pharmacokinetic studies where more precise data are required.
There currently is some confusion concerning the general value of internal standardization. The present study and theory (5) provide both general and specific insights. Equations 3a, 3b, and 6 yield a general criterion for when internal standardization will improve precision. When o can be neglected (because A is large), internal standardization will benefit precision whenever (2ev,.,2 + cud,,2) < (2cv,,,2 + cud,,2). When o, is the major contribution to cv (small A), internal standardization will generally adversely affect precision. For the assays of (4,6), internal standardization reduces assay CV by about half in each case (large A). Sample losses during manual samplepretreatment procedures are probably even more pronounced than in the automated assays of (4,6) (see later discussion), and are fully correctable by internal standardization.
Therefore, even greater benefits from internal standardization will probably accrue in most manual HPLC assays. Structural requirements of an internal standard.
It is commonly
believed that an internal standard should match the molecular structure and physical properties of the analyte as closely as possible. The present study and the theory (5) suggest that this requirement is often unnecessary. The data of Tables 3 and 5 for the procedures of ref. 4 , as well as additional data of a similar kind, show a strong correlation of assay precision with only one property of the internal standard: how closely it elutes to the analyte band. That is, the best internal standard will have a k' value within about ±30% of that of the analyte. Furthermore, as seen in and to minimize ionization of the analyte in the aqueous phase (for extraction into an organic phase). These conditions favor maximum recovery of analyte during extraction, and minimize variations in extraction (5) . In this case, it is not necessary to match values of K and pI( for analyte and internal standard (which would be difficult in any case). It is only necessary that (a) the internal standard be non-ionized in the aqueous phase and (b) the extraction be near 100%.
Finally, the internal standard should never be used in an attempt to correct for analyte losses during an evaporation step. It is in practice impossible to exactly match the volatilities of analyte and internal standard under the conditions of evaporation.
The best approach is to select conditions (5) that ensure 100% recovery of analyte from the evaporation step. The procedure used for adding the internal standard to the sample also affects assay precision. For example, should it be added directly to the sample, to the aqueous phase, or to the organic extraction solvent? A decision for a given assay can be made on the basis of the discussion in ref. 5, as summarized in Table 6 . For manual operation within the clinical laboratory, we recommend that the internal standard be added via the aqueous extraction solvent. In the case of the FAST-LC system, the benefit of internal standardization is only achieved if the internal standard is added to the sample before it is aspirated into the system (as in 6).
Analyte-Mass Effects
Analyte mass is a function of sample volume or concentration of analyte in the sample, or both. A decrease in analyte mass affects assay precision adversely:
(a) the CV for the volume of sample dispensed is increased if smaller volumes of sample are used, and (b) assay sensitivity (S) is decreased. The first effect increases cv,; the second effect increases imprecision due to o. In the case of the FAST-LC system-and of most manual assays-the decrease in assay sensitivity is of primary importance.
The result of some decrease in sample size is a proportionate decrease in the value of A in equations 3a and 3b. For the procedures under discussion (4, 6) it is possible to estimate the change in assay CV as follows. We begin with a value of S for a particular analyte and sample volume (as in 4, 6) . This allows us to calculate A for a given analyte concentration.
If sample size is then reduced by some factor z, the corresponding A value will be decreased by the same factor. Finally, the value of A defines the assay CV for given values of analyte concentration and sample volume, as in Figure 3 
